Cancer drugs show potential in fight against malaria
With malaria becoming increasingly drug-resistant, a team of UCF researchers is looking to use cancer drugs to accelerate the discovery of new life-saving therapies for the disease.
In a study funded by a 5-year $3.8 million grant from the National Institutes of Health, UCF molecular parasitologist Debopam Chakrabarti and cancer molecular biologist Ratna Chakrabarti are partnering with Nathanael Gray, co-leader of the cancer therapeutics research program at Stanford University and Elizabeth Winzeler, a malaria drug development expert from the University of California San Diego, to test cancer drugs for malaria-fighting ...









